Back to all people

Xiaofeng (Tina) Wang

FDA

1 appearance in the program

Sessions & presentations

PS24: From Signals to Action: AI-Enabled Anomaly Detection and Central Statistical Monitoring for Transdisciplinary Oversight in Neuropsychiatric Clinical Trials

Presentation: FDA Experiences with a Centralized Statistical Monitoring Tool

Parallel · Thu, Sep 17 , 4:15 PM

Presenting Author

↑